Skip to main content
AstraZeneca PLC (LON:AZN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
11,708
+118 (1.02%)
Feb 21, 2025, 5:11 PM BST

AstraZeneca Revenue

In the year 2024, AstraZeneca had annual revenue of $54.07B USD with 18.03% growth. AstraZeneca had revenue of $14.89B in the quarter ending December 31, 2024, with 23.84% growth.

Revenue
$54.07B
Revenue Growth
+18.03%
P/S Ratio
4.20
Revenue / Employee
$601.48K
Employees
89,900
Market Cap
181.54B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
GSK plc 31.38B
Haleon 11.24B
Smith & Nephew 4.46B
Hikma Pharmaceuticals 2.39B
ConvaTec Group 1.74B
HUTCHMED (China) 483.31M
Genus 668.80M
Oxford Nanopore Technologies 167.75M
Revenue Rankings

AstraZeneca News

More News